Ameet Mallik | executive |
Kristen Harrington-Smith | executive |
Mohamed Zaki | executive |
Patrick van Berkel | executive |
Jose Carmona | executive |
Naureen Quibria | analyst |
Lut Ming Cheng | analyst |
Gregory Renza | analyst |
Welcome to the ADC Therapeutics Fourth Quarter and Full Year 2023 Financial Results Conference Call. My name is [ Norma, ] and I'll be your operator for today's call. [Operator Instructions] I will now turn the call over to [ Nicole Riley, ] Head of Communications. Nicole, you may begin.
Thank you, operator.